Sponsors Cosmexchange 2017

Be part of the innovative Cosmexchange family!

Linking Global Strategies with Local Partners. Stratpharma’s dermatology team has many years of international experience in the dermatological therapeutic franchise with a current focus on scars. These products for scar management and abnormal scar prevention can be used alone or in combination with other more invasive therapies. The current products including Strataderm® hold existing registrations and are available in over 38 countries in Europe, Africa, North America and Asia.


Stratpharma, in conjunction with its development partners, is extending its focus by developing a range of innovative products for topical dermatology. These new products will extend upon the immediate focus on scar and late stage wound healing.

Using patented polymer technology, these products will deliver significant benefits to patients through ease of use, greater activation of API’s, safety and stability profiles as well as advances in gas permeability occlusion and protection.

Pipeline products will include those with problematic trans-dermal API delivery in indications that will benefit from the inherent physical properties of the “drug delivery system”.

Excellence in Laser Technology. From innovative ideas to tangible results. The history of laser technology is profoundly linked to DEKA. Therefore DEKA has chosen the number “10” as its brand name (“deka” means “10” in Greek) which means attainment of perfection and excellence. According to Pythagoras, the “10” is considered the perfect number and constitute the so-called Tetractys, formed from the sequence of the four numbers, and represent the cosmological principles.

This Florentine company has its roots in a culture that has made excellence of thought its dominant feature. An innovative corporate culture coupled with remarkable scientific expertise, make DEKA a world-class leader in the field of laser technology.

Due to its invaluable cultural heritage and unique historical background DEKA encompasses into its vision a promise of universal value: to turn every scientific discovery into a concrete benefit for mankind and to translate every technological innovation into ongoing improvements for the range of products and services it offers.

Choose Perfection. Fotona’s decades-long experience in the laser industry began 50 years ago in 1964, producing frontline laser devices for defense, optical communications, industrial, dental and medical applications throughout this time.

Fotona today is a world-leading medical laser company recognized for its innovative, award-winning laser systems for applications in aesthetics & dermatology, dentistry, surgery and gynecology. Based in the US and EU, with corporate headquarters in Dallas, Texas and Ljubljana, Slovenia, Fotona’s business philosophy is to continuously choose perfection to meet the needs of a highly demanding marketplace.

The company has one of the most highly educated workforces in the industry, with an exceptionally high number of PhDs specializing in laser and medical technology. Strong R&D capabilities have always been a key competitive advantage of the company, resulting in many patented solutions, including the OPTOflex® articulated arm, QSP (Quantum Square Pulse) and VSP (Variable Square Pulse) technologies, SMOOTH mode, Vacuum Cell technology, and many more.

Leading medical and aesthetic Laser and SWT equipmentScientific I2PL and laser based treatment solutions since 1997. Incontrovertible scientific evidence has stood behind every Ellipse solution since the first Ellipse system made its debut in 1997. And today, Ellipse has an international reputation for advanced laser and Intense Pulsed Light (I²PL) technology, impeccable quality and comprehensive customer support.

Application areas include treatment of acnesun-damaged skinhair removalwrinkle reduction, onychomycosis and the removal of pigmented and vascular lesions.

Every Ellipse product is developed in close cooperation with leading dermatologists and research institutions.

With thousands of users and and scores of clinical articles documenting the safety and effectiveness of Ellipse products, Ellipse is indeed clinically proven safe and effective.

Leading Growth PharmaAllergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma.  Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.

Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories. Open Science: Allergan is an industry leader in Open Science, the Company’s R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. This approach has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage pipeline programs in development.

French pharmaceutical laboratory. Pierre Fabre è il secondo laboratorio dermocosmetico più grande al mondo e il secondo gruppo farmaceutico privato francese. Nel 2015 ha realizzato un fatturato di oltre 2,2 miliardi di euro, di cui il 57% proveniente dal settore dermocosmetico e il 58% dal commercio internazionale. Pierre Fabre, la cui sede è storicamente ubicata nella regione del sud della Francia Languedoc-Roussillon-Midi-Pyrénées, è presente con le sue filiali in 43 nazioni e distribuisce i suoi prodotti in oltre 130 paesi.

I Laboratoires Pierre Fabre danno lavoro a circa 13.000 persone in tutto il mondo. I suoi prodotti coprono l'intero settore sanitario, a partire dai farmaci soggetti a prescrizione medica, fino ai dermocosmetici, passando per i farmaci da banco (medicina generale, igiene orale e medicina naturale). Nel 2015 l'azienda ha stanziato quasi 200 milioni di euro per il settore R&S, suddivisi fra oncologia, dermatologia, sistema nervoso centrale, automedicazione e dermocosmetica.

By listening to people with skin conditions, LEO Pharma develops complete care solutions that meet patient needs.

Founded in 1908, LEO Pharma is an independent, research-based pharmaceutical company.

LEO Pharma develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally. To realise our vision of becoming the preferred dermatology care partner improving people’s lives around the world, we are expanding into new regions and markets, reaching more patients and societies with drugs and therapies that address unmet medical needs. 

LEO Pharma has its own sales forces in 61 countries and employs around 5,000 employees worldwide. The company is headquartered in Denmark and is wholly owned by the LEO Foundation.

Enter in this world and discover innovative and extraordinarily simple products. LEM born by the tradition of preparing pharmaceutical compound designed and manufactured directly by pharmacists. The target is to extend our experience in the formulation of creams, emulsions and compounds for cleansing, targeted for various kind of skins. The concentration of the active molecules is higher than a normal beauty product. 

LEM products are particularly effective: studied and formulated almost as if they were drugs. Enter in this world and discover innovative and extraordinarily simple products. 
A Lab at your service able to realize and personalize your cream as you want it, even in the scent, with a result of simpleness, effectiveness, attractiveness and safety. 

Please reload

Sponsorship Opportunities




Large exhibition spaces (40 sqm) will be exclusively reserved to Platinum sponsors.

All other Companies will be able to rent regular booths located in the main catering area.


Two exhibition sizes will be available:

  • Economy size: 6 sqm exhibition space

  • Regular size: 12 sqm exhibition space


All delegates, accompanying persons and exhibitors are invited to join Cosmexchange Welcome Reception. This unique social event is a great opportunity for both attendees and exibitors to meet. Reception will be located within Congress premises in order to optimize interactivity.

Welcome reception will be scheduled on Thursday, 16 February 2017

Welcome Reception sponsorship includes:

  • company Logo displayed in the Welcome Reception area

  • company Logo displayed in Cosmexchange Programme on official website


Companies can choose to sponsor the 2 coffee break packages scheduled during the Congress – sponsorship will be reserved to a single company.

Coffee break packages will include:

  • company banner displayed in coffee break area to inform attendees of the courtesy provided

  • company Logo in Cosmexchange Programme on official website


Each company will be able to purchase up to 20 Cyber dinner tickets to be offered to delegates while their attend exhibition booths


Companies may provide their own workshop to be uploaded on Cosmexchange website or have a special workshop recorded during the congress.


The Company will provide the requested number of lanyards to the Organizers in due time with the Company’s logo.


Will supply ecological conference bags and printing.

Delegate bags sponsorship includes:

  • Printing Company logo on delegate bags

  • Company Logo on Cosmexchange programme & official website

  • Company will be entitled to supply mouse-pads and pen-drives with their logo on to be included in delegate bags


Companies may offer Congress registrations and accommodation to selected delegates.

To activate this kind of service,
please contact Cosmexchange Organizing Secretariat for furher information.